Your session is about to expire
← Back to Search
Behavioral Intervention
Smartwatch + App Monitoring for Medication Adherence in HIV (USE-MI Trial)
N/A
Recruiting
Led By Barry Saver, MD
Research Sponsored by Swedish Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Either a) have an HIV infection and are taking ART, or b) have risk factors for contracting HIV infection and are taking PrEP
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
USE-MI Trial Summary
This trial is testing a smartwatch and smartphone app to see if it can help people with HIV remember to take their medication, and to monitor if they are taking their medication accurately.
Who is the study for?
This trial is for individuals with HIV on antiretroviral therapy (ART) or those at risk taking PrEP. Participants must manage their own medication, use pill bottles the USE-MI system can monitor, speak English reasonably well, and attend monthly follow-ups.Check my eligibility
What is being tested?
The USE-MI study tests a new system combining a smartwatch and smartphone app designed to track when patients take their HIV medications and remind them if they forget, aiming to improve medication adherence in real-time.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves using technology for monitoring medication intake. However, participants may experience issues related to privacy or data security.
USE-MI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am HIV positive and on ART, or at risk for HIV and taking PrEP.
USE-MI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
System Acceptability
Secondary outcome measures
Accuracy of Capture of Pill-Taking by USE-MI
USE-MI Trial Design
1Treatment groups
Experimental Treatment
Group I: USE-MI SystemExperimental Treatment1 Intervention
Immediate use of the USE-MI smartwatch and smartphone app.
Find a Location
Who is running the clinical trial?
Swedish Medical CenterLead Sponsor
53 Previous Clinical Trials
8,234 Total Patients Enrolled
University of Massachusetts, AmherstOTHER
78 Previous Clinical Trials
467,712 Total Patients Enrolled
University of WashingtonOTHER
1,741 Previous Clinical Trials
1,847,706 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am HIV positive and on ART, or at risk for HIV and taking PrEP.I can visit the research office every month for follow-ups.
Research Study Groups:
This trial has the following groups:- Group 1: USE-MI System
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research study accepting new participants at present?
"Yes, the clinicaltrial.gov website confirms that this trial is still recruiting patients and has been since it was initially posted on August 1st 2019. The last edit to the data occured April 21st 2022 and currently there are 60 participants sought from a single medical centre."
Answered by AI
What is the target recruitment for this clinical trial?
"Indeed, the information found on clinicaltrials.gov corroborates that this medical trial is currently recruiting candidates. It was first uploaded to the website in August 2019 and has been recently updated as of April 2022 - its target population consists of 60 participants from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger